BI Bags Third Place For Humira Biosimilar in US With AbbVie Pact

 
• By David Wallace and Kevin Grogan
Balloons
Cyltezo will be the third Humira biosimilar to launch in 2023 • Source: Shutterstock

More from Legal & IP

More from Business